ID   PT1590-GFP
AC   CVCL_0C62
SY   GFP-PT1590
DR   cancercelllines; CVCL_0C62
DR   Wikidata; Q54948652
RX   PubMed=19847813;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>A); ClinVar=VCV000480961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0C61 ! PT1590
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
RX   PubMed=19847813; DOI=10.1002/ijc.24980;
RA   Gros S.J., Dohrmann T., Peldschus K., Schurr P.G., Kaifi J.T.,
RA   Kalinina T., Reichelt U., Mann O., Strate T.G., Adam G., Hoffman R.M.,
RA   Izbicki J.R.;
RT   "Complementary use of fluorescence and magnetic resonance imaging of
RT   metastatic esophageal cancer in a novel orthotopic mouse model.";
RL   Int. J. Cancer 126:2671-2681(2010).
//